BNP Paribas Financial Markets’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-151,686
| Closed | -$1.43M | – | 4263 |
|
|
2020
Q3 | $1.43M | Buy |
151,686
+5,607
| +4% | +$53.3K | ﹤0.01% | 1650 |
|
|
2020
Q2 | $1.12M | Sell |
146,079
-24,662
| -14% | -$189K | ﹤0.01% | 1756 |
|
|
2020
Q1 | $1.06M | Buy |
170,741
+19,509
| +13% | +$172K | ﹤0.01% | 1870 |
|
|
2019
Q4 | $1.84M | Buy |
151,232
+423
| +0.3% | +$4.62K | ﹤0.01% | 1715 |
|
|
2019
Q3 | $1.74M | Buy |
150,809
+4,743
| +3% | +$49.9K | ﹤0.01% | 1588 |
|
|
2019
Q2 | $1.46M | Sell |
146,066
-7,784
| -5% | -$84K | ﹤0.01% | 1607 |
|
|
2019
Q1 | $1.98M | Buy |
153,850
+33,947
| +28% | +$506K | ﹤0.01% | 1398 |
|
|
2018
Q4 | $1.82M | Buy |
119,903
+24,720
| +26% | +$471K | ﹤0.01% | 1352 |
|
|
2018
Q3 | $1.9M | Buy |
95,183
+7,003
| +8% | +$159K | ﹤0.01% | 1515 |
|
|
2018
Q2 | $1.72M | Buy |
88,180
+6,883
| +8% | +$152K | ﹤0.01% | 1540 |
|
|
2018
Q1 | $1.64M | Sell |
81,297
-2,334
| -3% | -$39.5K | ﹤0.01% | 1469 |
|
|
2017
Q4 | $1.11M | Buy |
83,631
+2,400
| +3% | +$36.2K | ﹤0.01% | 1912 |
|
|
2017
Q3 | $1.5M | Buy |
81,231
+6,147
| +8% | +$115K | ﹤0.01% | 1300 |
|
|
2017
Q2 | $1.38M | Buy |
75,084
+6,159
| +9% | +$122K | ﹤0.01% | 1380 |
|
|
2017
Q1 | $1.55M | Sell |
68,925
-21,874
| -24% | -$524K | ﹤0.01% | 1156 |
|
|
2016
Q4 | $3.16M | Buy |
90,799
+32,113
| +55% | +$959K | 0.01% | 747 |
|
|
2016
Q3 | $1.44M | Sell |
58,686
-48,270
| -45% | -$1.21M | 0.01% | 816 |
|
|
2016
Q2 | $2.56M | Buy |
106,956
+33,827
| +46% | +$776K | 0.01% | 746 |
|
|
2016
Q1 | $1.71M | Sell |
73,129
-52,303
| -42% | -$1.24M | 0.01% | 876 |
|
|
2015
Q4 | $3.79M | Buy |
125,432
+66,619
| +113% | +$2.15M | 0.01% | 728 |
|
|
2015
Q3 | $2.34M | Buy |
58,813
+41,169
| +233% | +$2.56M | 0.01% | 829 |
|
|
2015
Q2 | $1.22M | Buy |
17,644
+2,298
| +15% | +$145K | ﹤0.01% | 1067 |
|
|
2015
Q1 | $839K | Sell |
15,346
-6,926
| -31% | -$330K | ﹤0.01% | 1154 |
|
|
2014
Q4 | $949K | Sell |
22,272
-7,716
| -26% | -$279K | ﹤0.01% | 963 |
|
|
2014
Q3 | $957K | Sell |
29,988
-1,151
| -4% | -$24.5K | ﹤0.01% | 1265 |
|
|
2014
Q2 | $645K | Buy |
31,139
+1,633
| +6% | +$30.2K | ﹤0.01% | 1379 |
|
|
2014
Q1 | $539K | Buy |
29,506
+29,227
| +10,476% | +$621K | ﹤0.01% | 1395 |
|
|
2013
Q4 | $6.77K | Buy |
+279
| New | +$6.56K | ﹤0.01% | 2904 |
|
BNP Paribas Financial Markets's AMAG Position: Q4 2020 in Review
BNP Paribas Financial Markets sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 151,686 shares — an estimated $1.43M sold.
BNP Paribas Financial Markets first reported a position in AMAG in Q4 2013 and held it in 28 quarters. The position peaked at $3.79M in Q4 2015. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- BNP Paribas Financial Markets reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- BNP Paribas Financial Markets sold 151,686 AMAG Pharmaceuticals shares in Q4 2020, an estimated $1.43M.
- BNP Paribas Financial Markets first reported a position in AMAG Pharmaceuticals in Q4 2013 and held it in 28 quarters.
- BNP Paribas Financial Markets's AMAG Pharmaceuticals position peaked at $3.79M in Q4 2015.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2020, filed 10 Feb 2021.